- Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in childrenTea Andabaka
School of Medicine, University of Split, Split, Croatia
Cochrane Database Syst Rev 4:CD006602. 2013..The efficacy and safety of palivizumab has been evaluated in multicentre, randomised controlled trials (RCTs) and a large number of economic evaluations (EEs) have tested its cost-effectiveness...
- Parental administration of antipyretics to children with upper respiratory tract infections without consultation with a physicianTea Andabaka
Ewopharma Ltd, Zagreb, Croatia
Croat Med J 52:48-54. 2011....